关注
Kyrylo Klimenko
Kyrylo Klimenko
在 unistra.fr 的电子邮件经过验证
标题
引用次数
引用次数
年份
Chemical space mapping and structure–activity analysis of the ChEMBL antiviral compound set
K Klimenko, G Marcou, D Horvath, A Varnek
Journal of chemical information and modeling 56 (8), 1438-1454, 2016
452016
QSAR modelling of a large imbalanced aryl hydrocarbon activation dataset by rational and random sampling and screening of 80,086 REACH pre-registered and/or registered substances
K Klimenko, SA Rosenberg, M Dybdahl, EB Wedebye, NG Nikolov
PLoS One 14 (3), e0213848, 2019
242019
Novel enhanced applications of QSPR models: temperature dependence of aqueous solubility
K Klimenko, V Kuz'min, L Ognichenko, L Gorb, M Shukla, N Vinas, ...
Journal of Computational Chemistry 37 (22), 2045-2051, 2016
202016
Virtual screening, synthesis and biological evaluation of DNA intercalating antiviral agents
K Klimenko, S Lyakhov, M Shibinskaya, A Karpenko, G Marcou, ...
Bioorganic & Medicinal Chemistry Letters 27 (16), 3915-3919, 2017
192017
The solubility of gases in ionic liquids: a chemoinformatic predictive and interpretable approach
GVSM Carrera, J Inês, CES Bernardes, K Klimenko, K Shimizu, ...
ChemPhysChem 22 (21), 2190-2200, 2021
122021
In silico identification of endogenous and exogenous agonists of Estrogen-related receptor α
K Klimenko
Computational Toxicology 10, 105-112, 2019
72019
Water Solubility Trends in Ionic Liquids: The Quantitative Structure–Property Relationship Model versus Molecular Dynamics
CES Bernardes, K Klimenko, JN Canongia Lopes
The Journal of Physical Chemistry B 125 (41), 11491-11497, 2021
62021
QSPR Modeling of Liquid‐liquid Equilibria in Two‐phase Systems of Water and Ionic Liquid
KO Klimenko, JM Inês, JMSS Esperança, LPN Rebelo, J Aires‐de‐Sousa, ...
Molecular informatics 39 (9), 2000001, 2020
62020
QSAR modeling of different minimum potency levels for in vitro human CAR activation and inhibition and screening of 80,086 REACH and 54,971 US substances
KK Chinen, K Klimenko, C Taxvig, NG Nikolov, EB Wedebye
Computational Toxicology 14, 100121, 2020
62020
R‐based Tool for a Pairwise Structure‐activity Relationship Analysis
K Klimenko
Molecular Informatics 37 (4), 1700094, 2018
62018
SelinfDB: a database of selectivity at infinite dilution for liquid–liquid extraction
K Klimenko, JM Ines, JMSS Esperanca, J Aires-de-Sousa, GVSM Carrera
Industrial & Engineering Chemistry Research 60 (22), 8209-8217, 2021
42021
Examining the evidence of non-monotonic dose-response in Androgen Receptor agonism high-throughput screening assay
K Klimenko
Toxicology and Applied Pharmacology 410, 115338, 2021
42021
QSPR modeling of selectivity at infinite dilution of ionic liquids
K Klimenko, GVSM Carrera
Journal of Cheminformatics 13, 1-10, 2021
22021
Aminoalkoxyfluorenones and aminoalkoxybiphenyls: DNA binding modes
SO Zanoza, KO Klimenko, GV Maltzev, TI Bykova, IA Levandovskiy, ...
Bioorganic Chemistry 86, 52-60, 2019
22019
Computer-aided drug design of broad-spectrum antiviral compounds
K Klimenko
Université de Strasbourg, 2017
12017
INDENO [1, 2, 3-DE] PHTHALAZIN-3 (2H)-ONE AND ITS ANALOGS–SYNTHESIS AND ANTIINFLAMMATORY PROPERTIES
KV Bondar, KО Klimenko, ОІ Alexandrova, ІА Kravchenko, IA Schepetkin, ...
Вісник Одеського національного університету. Хімія 21 (1 (57)), 59-71, 2016
12016
Prediction of the Phase Composition Profile of Three‐Compound Mixtures in Liquid‐Liquid Equilibrium: A Chemoinformatics Approach
GVSM Carrera, ML Cruz, K Klimenko, JMSS Esperança, ...
ChemPhysChem 23 (24), e202200300, 2022
2022
Computer-aided drug design of broad-spectrum antiviral compounds| Theses. fr
K Klimenko
Strasbourg, 2017
2017
QSPR АНАЛІЗ ТЕМПЕРАТУРНОЇ ЗАЛЕЖНОСТІ РОЗЧИННОСТІ ОРГАНІЧНИХ СПОЛУК У ВОДІ
KA Klimenko, LN Ognichenko, VE Kuz’min, AG Artemenko, LG Gorb
Вісник Одеського національного університету. Хімія 17 (2 (42)), 32-41, 2012
2012
How much can you trust fluorescence quenching to determine drug binding site in Human Serum Albumin?
K KLIMENKO
系统目前无法执行此操作,请稍后再试。
文章 1–20